text.skipToContent text.skipToNavigation

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

Quick Order
If not, click 'cancel'. You can also save this item for later.
Cancel
If not, click 'cancel'. You can also save this item for later.
Cancel

Comprehensive pharmaceutical impurity testing solutions from LGC Standards

impurity reference standards_671 x 268px.jpg

14,000+ High-Quality Impurity Reference Standards for Pharmaceutical Analysis

Ensure accuracy and meet regulatory requirements with LGC’s high-purity impurity reference standards. Backed by ISO 17034 and ISO/IEC 17025, our Mikromol Reference Materials and TRC analytical standards support safer, more effective medicines worldwide.

Explore now

Two scientists looking at a document in a lab

Speak to an Expert

Our team of experts is ready to assist you with your impurities testing challenges.

Contact us

Welcome to our impurities hub, where you will find a wide range of tools and technical resources – all aimed at improving your impurities testing for pharmaceutical products.

 

From initial drug substance manufacturing to the packaging of a finished drug product, sources of impurities in pharmaceutical products are many and varied. Potential risk factors range from process related impurities that can occur during the active pharmaceutical ingredient (API) development process to extractable and leachable (E&L) impurities formed when finished drug products interact with a range of packaging, closure and delivery components.

 

In the worst cases, pharmaceutical impurities can compromise patient safety – reducing therapeutic efficacy, causing unpredictable side effects, and even increasing cancer risks. But impurities in pharmaceutical products can also have a devastating effect on manufacturers’ profitability and reputation – as evidenced by several high-profile drug recalls linked to nitrosamine contamination.

 


Discover related resources

White papers
White papers
Managing impurities in pharmaceutical manufacturing
Read now
Brochures
Brochures
Characterisation of impurity standards interactive guide
View now
Catalogues
Catalogues
Research chemicals and analytical standards for innovative research and analysis
Discover now
White papers
White papers
Quantifying pharmaceutical impurities: External reference standards vs Relative response factors (RRFs)
Read now
Brochures
Brochures
LGC pharmaceutical services
Discover now
White papers
White papers
Characterisation of non-compendial impurity standards: What defines 'Good enough?'
Read now
Posters
Posters
Characterisations of impurity standards: What defines 'Good enough?'
View now
White papers
White papers
Advancing transporter-based predictions: Practical solutions for toxicity and drug-drug interactions
Read now
Articles
Articles
WHO releases new guidelines for preventing nitrosamine contamination
Read now
White papers
White papers
A Guide to pharmaceutical stress testing
Read now
Posters
Posters
NDSRI risk assessment and trace-level analysis of N-nitrosamines
View now
Articles
Articles
Unveiling the hidden threat: nitrosamine impurities in medicines
Read now

LGC Mikromol | Key Features of impurity Certificates of Analysis

Explore Mikromol's Impurity Certificates of Analysis! Learn how our CoAs provide comprehensive data, ensuring the highest standards of quality and compliance for your pharmaceutical needs.

Watch now
Punchout session timeout warning

Your punchout session will expire in1 min59 sec.

Select "Continue session" to extend your session.